TD Cowen’s recent upgrade of Array Technologies (ARRY) has refocused attention on the solar tracker maker, as the firm cited improving execution, muted expectations, and a valuation gap versus peers.

Array Digital Infrastructure's cell tower business grew by 68% over its year-ago comp following T-Mobile's master license agreement. The tower company is set to see some near-term headwinds as DISH ...

A new report suggests increased investments in solar power on school grounds could help reduce energy costs in Centre County and across Pennsylvania. The study, published this week by the ...

Albuquerque-based Array Technologies reported Thursday a 20% jump in revenue from the previous quarter, beating analyst expectations. In an earnings call, company officials reported $362.2 million in ...

Opus Genetics, Inc. announced positive topline results from its VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% for treating presbyopia, achieving its primary and key ...

VEGA-3 trial showed significant efficacy of phentolamine ophthalmic solution 0.75% in improving near vision in presbyopia patients compared to placebo. The trial met its primary endpoint with 27.2% ...

GUANGZHOU, China, June 20, 2025 /PRNewswire/ -- Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today ...

To satisfy the seafood needs of billions of people, offering them access to a more biodiverse array of fish creates opportunities to mix-and-match species to obtain better nutrition from smaller ...

ITHACA, N.Y. - To satisfy the seafood needs of billions of people, offering them access to a more biodiverse array of fish creates opportunities to mix-and-match species to obtain better nutrition ...

A lot of us have trained ourselves to expect the worst—not because we want to be pessimists, but because figuring out how to be more positive often feels like an abstract concept, tied to forced, ...

For the nearly 30 percent of major depressive disorder patients who are resistant to treatment, ketamine provides some amount of normalcy, but it requires frequent treatment and can have side effects.